ID   TTPA_RAT                Reviewed;         278 AA.
AC   P41034;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   24-JUL-2024, entry version 143.
DE   RecName: Full=Alpha-tocopherol transfer protein;
DE            Short=Alpha-TTP;
GN   Name=Ttpa; Synonyms=Tpp1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 77-87; 156-165; 178-182
RP   AND 212-216.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8349655; DOI=10.1016/s0021-9258(17)46761-5;
RA   Sato Y., Arai H., Miyata A., Tokita S., Yamamoto K., Tanabe T., Inoue K.;
RT   "Primary structure of alpha-tocopherol transfer protein from rat liver.
RT   Homology with cellular retinaldehyde-binding protein.";
RL   J. Biol. Chem. 268:17705-17710(1993).
CC   -!- FUNCTION: Binds alpha-tocopherol, enhances its transfer between
CC       separate membranes, and stimulates its release from liver cells. Binds
CC       both phosphatidylinositol 3,4-bisphosphate and
CC       phosphatidylinositolphosphatidylinol 4,5-bisphosphate; the resulting
CC       conformation change is important for the release of the bound alpha-
CC       tocopherol (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer and homotetramer. Phosphatidylinositol 4,5-
CC       bisphosphate binding induces the formation of homotetramers.
CC       Phosphatidylinositol 3,4-bisphosphate is less efficient in inducing
CC       tetramerization (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Liver.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D16339; BAA03843.1; -; mRNA.
DR   PIR; A47404; A47404.
DR   RefSeq; NP_037180.1; NM_013048.2.
DR   AlphaFoldDB; P41034; -.
DR   SMR; P41034; -.
DR   IntAct; P41034; 1.
DR   STRING; 10116.ENSRNOP00000009611; -.
DR   iPTMnet; P41034; -.
DR   PhosphoSitePlus; P41034; -.
DR   PaxDb; 10116-ENSRNOP00000009611; -.
DR   GeneID; 25571; -.
DR   KEGG; rno:25571; -.
DR   UCSC; RGD:3915; rat.
DR   AGR; RGD:3915; -.
DR   CTD; 7274; -.
DR   RGD; 3915; Ttpa.
DR   VEuPathDB; HostDB:ENSRNOG00000007139; -.
DR   eggNOG; KOG1471; Eukaryota.
DR   HOGENOM; CLU_046597_1_2_1; -.
DR   InParanoid; P41034; -.
DR   OrthoDB; 522503at2759; -.
DR   PhylomeDB; P41034; -.
DR   Reactome; R-RNO-8877627; Vitamin E.
DR   PRO; PR:P41034; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000007139; Expressed in liver and 17 other cell types or tissues.
DR   GO; GO:0005770; C:late endosome; IDA:RGD.
DR   GO; GO:0120013; F:lipid transfer activity; ISO:RGD.
DR   GO; GO:1902936; F:phosphatidylinositol bisphosphate binding; IBA:GO_Central.
DR   GO; GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0019842; F:vitamin binding; IDA:RGD.
DR   GO; GO:0008431; F:vitamin E binding; IDA:RGD.
DR   GO; GO:0001892; P:embryonic placenta development; ISO:RGD.
DR   GO; GO:0120009; P:intermembrane lipid transfer; ISS:UniProtKB.
DR   GO; GO:0051452; P:intracellular pH reduction; IDA:RGD.
DR   GO; GO:1904036; P:negative regulation of epithelial cell apoptotic process; IDA:RGD.
DR   GO; GO:0090212; P:negative regulation of establishment of blood-brain barrier; ISO:RGD.
DR   GO; GO:0001890; P:placenta development; ISO:RGD.
DR   GO; GO:1900223; P:positive regulation of amyloid-beta clearance; ISO:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0009268; P:response to pH; IDA:RGD.
DR   GO; GO:0009636; P:response to toxic substance; ISO:RGD.
DR   GO; GO:0042360; P:vitamin E metabolic process; ISO:RGD.
DR   GO; GO:0051180; P:vitamin transport; ISS:UniProtKB.
DR   CDD; cd00170; SEC14; 1.
DR   Gene3D; 1.20.5.1200; Alpha-tocopherol transfer; 1.
DR   Gene3D; 3.40.525.10; CRAL-TRIO lipid binding domain; 1.
DR   Gene3D; 1.10.8.20; N-terminal domain of phosphatidylinositol transfer protein sec14p; 1.
DR   InterPro; IPR001251; CRAL-TRIO_dom.
DR   InterPro; IPR036865; CRAL-TRIO_dom_sf.
DR   InterPro; IPR011074; CRAL/TRIO_N_dom.
DR   InterPro; IPR036273; CRAL/TRIO_N_dom_sf.
DR   PANTHER; PTHR10174:SF225; ALPHA-TOCOPHEROL TRANSFER PROTEIN; 1.
DR   PANTHER; PTHR10174; ALPHA-TOCOPHEROL TRANSFER PROTEIN-RELATED; 1.
DR   Pfam; PF00650; CRAL_TRIO; 1.
DR   Pfam; PF03765; CRAL_TRIO_N; 1.
DR   PRINTS; PR00180; CRETINALDHBP.
DR   SMART; SM01100; CRAL_TRIO_N; 1.
DR   SMART; SM00516; SEC14; 1.
DR   SUPFAM; SSF52087; CRAL/TRIO domain; 1.
DR   SUPFAM; SSF46938; CRAL/TRIO N-terminal domain; 1.
DR   PROSITE; PS50191; CRAL_TRIO; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Direct protein sequencing; Lipid-binding; Reference proteome;
KW   Transport.
FT   CHAIN           1..278
FT                   /note="Alpha-tocopherol transfer protein"
FT                   /id="PRO_0000210766"
FT   DOMAIN          88..253
FT                   /note="CRAL-TRIO"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00056"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         185
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57658"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BWP5"
FT   BINDING         187
FT                   /ligand="(+)-alpha-tocopherol"
FT                   /ligand_id="ChEBI:CHEBI:18145"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BWP5"
FT   BINDING         190..192
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57658"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BWP5"
FT   BINDING         208..211
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-4,5-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58456"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BWP5"
FT   BINDING         217
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57658"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BWP5"
FT   BINDING         221
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57658"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BWP5"
SQ   SEQUENCE   278 AA;  31846 MW;  96F16E3F227F140C CRC64;
     MAEMRPGPVV GKQLNEQPDH SPLVQPGLAE LRRRAQEEGV PETPQPLTDA FLLRFLRARD
     FDLDLAWRLM KNYYKWRAEC PELSADLHPR SILGLLKAGY HGVLRSRDPT GSRVLIYRIS
     YWDPKVFTAY DVFRVSLITS ELIVQEVETQ RNGVKAIFDL EGWQISHAFQ ITPSVAKKIA
     AVVTDSFPLK VRGIHLINEP VIFHAVFSMI KPFLTEKIKG RIHLHGNNYK SSLLQHFPDI
     LPLEYGGNES SMEDICQEWT NFIMKSEDYL SSISETIQ
//
